World J Mens Health.  2020 Jan;38(1):24-31. 10.5534/wjmh.180103.

Upcoming Aging Society and Men's Health: Focus on Clinical Implications of Exercise and Lifestyle Modification

• Park B
• Lee YJ

• KMID: 2465407
• DOI: http://doi.org/10.5534/wjmh.180103

Abstract

Recent epidemiological research has indicated that men have increased health risks due to biological and social factors. Research in the area of men's health has been focused on disease events and subsequent disabilities. In future aging societies, more attention should be paid to the importance of men's health because a decreased quality of life and increased social burden are impending unless proper maneuvers are taken to slow the development and progression of morbidity through the use of preventive strategies. The adoption of a healthier lifestyle and the early identification and management of risk factors are very important and can be an initiative for prevention and for slowing the progression of morbidities with related quality of life issues. Males are rather vulnerable in terms of health, and conscious and active efforts are required to promote their health in an aging society. Here, we hope to shed light on the influence of lifestyle modifications and their clinical implications on men's health.

Keyword

Exercise; Healthy aging; Healthy lifestyle; Men's health; Testosterone

MeSH Terms

Aging*
Hope
Humans
Life Style*
Male
Men's Health*
Quality of Life
Risk Factors
Testosterone
Testosterone

Figure

• 

  Fig. 1 Schematic view of the interrelationship between low testosterone levels and metabolic alterations and their clinical implications. IL: interleukin.

• 

  Fig. 2 Key considerations for proper exercise for men, with respect to male hormones.

• 

  Fig. 3 Plausible integrative hormonal interactions among the hypothalamus-pituitary-adrenal-thyroid-gonad axis (HPA-T-G) axis.

Reference

1. Austad SN. Why women live longer than men: sex differences in longevity. Gend Med. 2006; 3:79–92. PMID: 16860268.

2. Barford A, Dorling D, Davey Smith G, Shaw M. Life expectancy: women now on top everywhere. BMJ. 2006; 332:808. PMID: 16601021.

3. Zarulli V, Barthold Jones JA, Oksuzyan A, Lindahl-Jacobsen R, Christensen K, Vaupel JW. Women live longer than men even during severe famines and epidemics. Proc Natl Acad Sci U S A. 2018; 115:E832–E840. PMID: 29311321.

4. Tsujimura A. The relationship between testosterone deficiency and men's health. World J Mens Health. 2013; 31:126–135. PMID: 24044107.

5. Park B. Functional approach to chronic fatigue and energy homeostasis in perspective of adrenal hormones. J Korean Inst Funct Med. 2018; 1:32–38.

6. Park BJ, Shim JY, Lee YJ, Lee JH, Lee HR. Inverse relationship between bioavailable testosterone and subclinical coronary artery calcification in non-obese Korean men. Asian J Androl. 2012; 14:612–615. PMID: 22522505.

7. Mackay J. The global epidemiology of tobacco and related chronic diseases. Public Health. 2012; 126:199–201. PMID: 22326602.

8. Centers for Disease Control and Prevention (CDC). Quitting smoking among adults: United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2011; 60:1513–1519. PMID: 22071589.

9. Song YM, Cho HJ. Risk of stroke and myocardial infarction after reduction or cessation of cigarette smoking: a cohort study in Korean men. Stroke. 2008; 39:2432–2438. PMID: 18617660.

10. Song YM, Sung J, Cho HJ. Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men. J Clin Oncol. 2008; 26:5101–5106. PMID: 18838704.

11. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax. 2002; 57:967–972. PMID: 12403880.

12. Jang SH, Sheen S, Kim HY, Yim HW, Park BY, Kim JW, et al. The Korean guideline for lung cancer screening. J Korean Med Assoc. 2015; 58:291–301.

13. DeLay KJ, Haney N, Hellstrom WJ. Modifying risk factors in the management of erectile dysfunction: a review. World J Mens Health. 2016; 34:89–100. PMID: 27574592.

14. McVary KT, Carrier S, Wessells H. Smoking and erectile dysfunction: evidence based analysis. J Urol. 2001; 166:1624–1632. PMID: 11586190.

15. Zhao J, Leung JY, Lin SL, Schooling CM. Cigarette smoking and testosterone in men and women: a systematic review and meta-analysis of observational studies. Prev Med. 2016; 85:1–10. PMID: 26763163.

16. Park B, Lee HR, Lee YJ. Alcoholic liver disease: focus on prodromal gut health. J Dig Dis. 2016; 17:493–500. PMID: 27356233.

17. Park BJ, Lee YJ, Lee HR. Chronic liver inflammation: clinical implications beyond alcoholic liver disease. World J Gastroenterol. 2014; 20:2168–2175. PMID: 24605015.

18. Jiann BP. Effect of alcohol consumption on the risk of erectile dysfunction. Urol Sci. 2010; 21:163–168.

19. Arackal BS, Benegal V. Prevalence of sexual dysfunction in male subjects with alcohol dependence. Indian J Psychiatry. 2007; 49:109–112. PMID: 20711392.

20. Sarkola T, Eriksson CJ. Testosterone increases in men after a low dose of alcohol. Alcohol Clin Exp Res. 2003; 27:682–685. PMID: 12711931.

21. Moreira LB, Fuchs FD, Moraes RS, Bredemeier M, Duncan BB. Alcohol intake and blood pressure: the importance of time elapsed since last drink. J Hypertens. 1998; 16:175–180. PMID: 9535144.

22. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011; 22:1958–1972. PMID: 21307158.

23. US Department of Health and Human Services, US Department of Agriculture. Dietary guidelines for Americans, 2015–2020. Washington D.C.: US Department of Health and Human Services, US Department of Agriculture;2015.

24. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444:881–887. PMID: 17167477.

25. Logue J, Murray HM, Welsh P, Shepherd J, Packard C, Macfarlane P, et al. Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart. 2011; 97:564–568. PMID: 21324888.

26. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev. 2012; 13:985–1000. PMID: 22731928.

27. Kang HT, Shim JY, Lee HR, Park BJ, Linton JA, Lee YJ. Trends in prevalence of overweight and obesity in Korean adults, 1998-2009: the Korean National Health and Nutrition Examination Survey. J Epidemiol. 2014; 24:109–116. PMID: 24531001.

28. Park B, Lee YJ. Metabolic syndrome and its components as risk factors for prolonged corrected QT interval in apparently healthy Korean men and women. J Clin Lipidol. 2018; 12:1298–1304. PMID: 30100158.

29. Sanchez E, Pastuszak AW, Khera M. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017; 6:28–36. PMID: 28217448.

30. Park SJ, Kang HT, Nam CM, Park BJ, Linton JA, Lee YJ. Sex differences in the relationship between socioeconomic status and metabolic syndrome: the Korean National Health and Nutrition Examination Survey. Diabetes Res Clin Pract. 2012; 96:400–406. PMID: 22245695.

31. Salam R, Kshetrimayum AS, Keisam R. Testosterone and metabolic syndrome: the link. Indian J Endocrinol Metab. 2012; 16 Suppl 1:S12–S19. PMID: 22701831.

32. Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2003; 58:165–170. PMID: 12586855.

33. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997; 82:1661–1667. PMID: 9177359.

34. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003; 58:618–625. PMID: 12865477.

35. Shin JY, Park EK, Park BJ, Shim JY, Lee HR. High-normal glucose levels in non-diabetic and pre-diabetic men are associated with decreased testosterone levels. Korean J Fam Med. 2012; 33:152–156. PMID: 22787537.

36. Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003; 14:S233–S236. PMID: 12874437.

37. Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano Iii IN, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med. 2010; 7:156–165. PMID: 19694925.

38. Kumagai H, Zempo-Miyaki A, Yoshikawa T, Tsujimoto T, Tanaka K, Maeda S. Lifestyle modification increases serum testosterone level and decrease central blood pressure in overweight and obese men. Endocr J. 2015; 62:423–430. PMID: 25753766.

39. Zhang H, Lin S, Gao T, Zhong F, Cai J, Sun Y, et al. Association between sarcopenia and metabolic syndrome in middleaged and older non-obese adults: a systematic review and meta-analysis. Nutrients. 2018; 10:E364. PMID: 29547573.

40. Shin MJ, Jeon YK, Kim IJ. Testosterone and sarcopenia. World J Mens Health. 2018; 36:192–198. PMID: 29756416.

41. Jankowska EA, Rozentryt P, Ponikowska B, Hartmann O, Kustrzycka-Kratochwil D, Reczuch K, et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009; 301:1892–1901. PMID: 19436016.

42. Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellström D, et al. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab. 2009; 94:2482–2488. PMID: 19401373.

43. Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016; 133:1104–1114. PMID: 26976915.

44. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 150:396–404. PMID: 19293072.

45. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014; 63:2935–2959. PMID: 24239921.

46. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017; 390:2673–2734. PMID: 28735855.

47. Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, et al. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2016; 131:226–238. PMID: 26433119.

48. Laukkanen T, Kunutsor S, Kauhanen J, Laukkanen JA. Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged Finnish men. Age Ageing. 2017; 46:245–249. PMID: 27932366.

49. Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006; 155:773–781. PMID: 17132744.

50. Jung HJ, Shin HS. Effect of testosterone replacement therapy on cognitive performance and depression in men with testosterone deficiency syndrome. World J Mens Health. 2016; 34:194–199. PMID: 28053949.

51. Hayes LD, Grace FM, Baker JS, Sculthorpe N. Exercise-induced responses in salivary testosterone, cortisol, and their ratios in men: a meta-analysis. Sports Med. 2015; 45:713–726. PMID: 25655373.

52. Hayes LD, Herbert P, Sculthorpe NF, Grace FM. Exercise training improves free testosterone in lifelong sedentary aging men. Endocr Connect. 2017; 6:306–310. PMID: 28515052.

53. Cho DY, Yeo JK, Cho SI, Jung JE, Yang SJ, Kong DH, et al. Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial. Asian J Androl. 2017; 19:602–607. PMID: 27427553.

54. Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 2009; 30:726–733. PMID: 19578132.

55. Iolascon G, Di Pietro G, Gimigliano F, Mauro GL, Moretti A, Giamattei MT, et al. Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed). Clin Cases Miner Bone Metab. 2014; 11:215–221. PMID: 25568656.

56. Park BJ, Lee YJ. Integrative approach to elderly frailty. Korean J Fam Med. 2010; 31:747–754.

57. O'Leary CB, Hackney AC. Acute and chronic effects of resistance exercise on the testosterone and cortisol responses in obese males: a systematic review. Physiol Res. 2014; 63:693–704. PMID: 25157657.

58. Hansen S, Kvorning T, Kjaer M, Sjøgaard G. The effect of short-term strength training on human skeletal muscle: the importance of physiologically elevated hormone levels. Scand J Med Sci Sports. 2001; 11:347–354. PMID: 11782267.

59. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J Neuroendocrinol. 2002; 14:506–513. PMID: 12047726.

60. Harris AR, Vagenakis AG, Braverman LE. Sex-related differences in outer ring monodeiodination of thyroxine and 3,3′,5′-triiodothyronine by rat liver homogenates. Endocrinology. 1979; 104:645–652. PMID: 436722.

61. Miyashita K, Murakami M, Iriuchijima T, Takeuchi T, Mori M. Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone. Mol Cell Endocrinol. 1995; 115:161–167. PMID: 8824891.

62. Lopresti AL, Hood SD, Drummond PD. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord. 2013; 148:12–27. PMID: 23415826.